We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoprobe Reveals Dynamics of Plaque Development in Living Alzheimer's Cells

By LabMedica International staff writers
Posted on 27 Jun 2016
A novel nanoscale plasmonic probe was used to follow the formation of toxic tau and amyloid (A-beta) plaques in living, anesthetic treated neuroblastoma cells.

Investigators at Massachusetts General Hospital (Boston, USA) and the Harvard University Medical School (Boston, MA, USA) capitalized on novel nanoplasmonic fiber tip probe (nFTP) technology to study the dynamic relations between A-beta and tau proteins in single living neuroblastoma cells.

Plasmonic resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. More...
An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light. In the current study a 50-nanometer diameter gold nanorod acted as the plasmon resonance biosensor.

The investigators reported results obtained by using the nFTP in the June 6, 2016, online edition of the journal Nano Letters. They found that A-beta42 generation, under clinically relevant anesthetic treatment, preceded tau phosphorylation, which then facilitated further A-beta42 generation. This observation was supported by measuring proteins in cell lysates using the ultrasensitive label-free photonic crystal nanosensors. Thus, the nFTP technique proved to be an advanced method for investigating protein expression and post-translational modification in live cells and for determining outcomes of intervention of Alzheimer’s disease and other neurodegenerative disorders.

"We have brought the traditional immunoassay into living cells with exquisite sensitivity," said senior author Dr. Qimin Quan, a junior fellow at the Rowland Institute of the Harvard University Medical School. "The device is still limited in its ability to measure a large number of single cells, requiring further improvement. But its high-sensitivity, label-free and single-cell capability make it a unique tool for diagnosing clinically obtained limited samples."

Related Links:
Massachusetts General Hospital
Harvard University Medical School

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.